Harvard Pilgrim Health Care Institute

🌟Meet the speaker🌟 Antibiotic susceptibility patterns used for epidemiologic surveillance of Staphylococcus aureus Organised by the ISAC MRSA Working Group 📆11 July 2024 ⏰ 15.00 CET / 09.00 EST* Dr Sanjat Kanjilal is an Assistant Professor in the Department of Population Medicine at the Harvard Pilgrim Health Care Institute and the Associate Medical Director of Clinical Microbiology at the Brigham & Women’s Hospital (BWH). He is also an infectious diseases physician at the BWH and the course director of HST 040, Mechanisms of Microbial Pathogenesis, at Harvard Medical School. Dr Kanjilal's research interests focus on harnessing observational and experimental data to improve the diagnosis and management of infectious diseases. Specific areas of work include the development of decision support tools built over artificial intelligence models that assist healthcare providers in a variety of tasks such as choosing optimal antibiotic treatments and diagnostic testing strategies and in granular modeling of antimicrobial resistance for infection control. Don't miss his talk on "Insights into the changing epidemiology of S. aureus in Boston, Massachusetts using routinely collected electronic health record data" at the upcoming webinar. Register ⬇ Dr Sanjat Kanjilal is an Assistant Professor in the Department of Population Medicine at the Harvard Pilgrim Health Care Institute and the Associate Medical Director of Clinical Microbiology at the Brigham & Women’s Hospital (BWH). #MRSA #staph #staphaureus #staphlococcal #staphinfection #healthcare #saureus #antibioticresistance #antibiotics #antimicrobialstewardship #antimicrobialresistance #antimicrobials #clinicalmicrobiology #globalhealth #publichealth

In this study of adults admitted to 241 US hospitals, broad-spectrum antibiotic use for suspected community-onset sepsis increased between 2017-2021, but resistant organisms were isolated in <10% of cases treated with broad-spectrum agents. https://ja.ma/3L4DKBW

🌟Webinar announcement🌟 ISAC is delighted to invite you to its next free webinar: "Antibiotic susceptibility patterns used for epidemiologic surveillance of S. aureus" Organised by the ISAC MRSA Working Group 📆11 July ⏰ 15.00 CET / 09.00 EST There have been recent studies in the US and Spain showing emerging resistance in MSSA to macrolides and to tetracyclines. ST398 S. aureus strains, initially identified as “livestock associated MRSA” are a fascinating example. Studies of clinical S. aureus strains have in some cases included molecular epidemiology suggesting that ST398 S. aureus strains may be responsible for a change in the relative prevalence of strains causing clinically significant disease. Other studies have examined national or transnational emergence of various increasingly common strains of MRSA and MSSA, using susceptibility patterns to track strain emergence or change over time. Join this webinar and hear from three experts in the field on these topics. PROGRAMME 1. Exploring the surveillance potential of phenotypic susceptibility tests in outpatient S. aureus infections among US Veterans, 2010-2019 Dr Margaret Carrel (University of Iowa) 2. A 2019 prospective survey of the genomic epidemiology of S. aureus in South America: results from the first StaphNET-SA network Dr Sabrina N. Di Gregorio (University of Buenos Aires) 3. Insights into the changing epidemiology of S. aureus in Boston, Massachusetts using routinely collected electronic health record data Dr Sanjat Kanjilal (Harvard University) MODERATORS Dr Michael David (University of Pennsylvania) Prof. Margreet Vos (ErasmusMC) REGISTER⬇ https://lnkd.in/e9vcsRF6 #MRSA #MSSA #SAureus #susceptibility #staph #infections #Staphylococcus #bacterium #bacteria #antibiotics #antimicrobials #antibioticresistance #antimicrobialresistance #antimicrobialstewardship #healthcare #globalhealth #publichealth #Staphylococcal

📣 Webinar recording and slides now available: "The NIH COVID-19 Diabetes Assessment (CODA) Study: Leveraging PCORnet for a Novel Cohort Study" with Russell Rothman of Vanderbilt University Medical Center and Jason Block of Harvard Medical School 🔗 https://bit.ly/4chzmep

The Annual Research Meeting is less than two weeks away! June us on June 29-July 2 in Baltimore! With a packed agenda and several onsite activities, we want to make sure that attendees are prepared and excited for what's in store. Learn more about what to expect at our online Attendee Resource Center: https://lnkd.in/eWpFbSNX Our new online agenda is now available! Search for sessions by type and theme, learn about our supporters and exhibitors, and more: https://lnkd.in/e_ikqz8v

Gestational diabetes affects 1 in 7 pregnancies and is the most common medical pregnancy complication worldwide. Cases of gestational diabetes are increasing and becoming more complex due to higher levels of risk factors, such as obesity. Without treatment, gestational diabetes can lead to increased risk of: - High blood pressure - Caesarean sections - Mental health conditions - Health complications later in life, such as type 2 diabetes and cardiovascular disease - Complications for the baby at delivery Testing and treatment for the condition often occurs late into the second or third trimester. Authors of a new Lancet Series call for earlier intervention to prevent complications and improve long-term health outcomes. “Our new Series emphasises the urgent need for a major shift in how [gestational diabetes] is first diagnosed and managed, not only during pregnancy but throughout the lifetime of mothers and their babies,” said Series lead, Prof. David Simmons. Find out more ▶️ https://hubs.li/Q02C0SG30